{"id":"W4367552266","doi":"10.1093/ehjcvp/pvad032","title":"Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease","year":2023,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Abbott Vascular; St. Jude Medical; CytoSorbents Europe; Intas Pharmaceuticals; Idorsia Pharmaceuticals; Terumo; Sanofi; Abiomed; Eisai; Biosensors International Group; Medicure; InfraRedx; Medicines Company; Canada Excellence Research Chairs, Government of Canada; Osprey Medical; Novo Nordisk; Daiichi-Sankyo; Regeneron Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Servier; Gilead Sciences; Bayer HealthCare; Cilag; Cardinal Health; Edwards Lifesciences; Amgen; Pfizer; Universität Basel","keywords":"Antithrombotic; Medicine; Intensive care medicine; Coronary artery disease; Terminology; Regimen; Fibrinolytic agent; Cardiology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001402696,0.001254613,0.004403069,0.0007345584,0.0002647445,0.0003648842,0.0003924472,0.000142905,0.0002419938],"category_scores_gemma":[0.00002412117,0.0008551893,0.007516617,0.0009792045,0.0002007659,0.0004505677,0.00005527059,0.001034618,0.0005187753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000557875,"about_ca_system_score_gemma":0.001172669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001047735,"about_ca_topic_score_gemma":7.265555e-7,"domain_scores_codex":[0.9924709,0.002866074,0.001159675,0.00103108,0.001534053,0.0009382613],"domain_scores_gemma":[0.9971072,0.0001069781,0.0003134938,0.001315834,0.0002059487,0.0009505594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001401193,0.001747256,0.007352949,0.007123766,0.05089832,0.01492677,0.0001625704,0.001006482,0.000001825918,0.000004201713,0.0005459684,0.9148287],"study_design_scores_gemma":[0.01378664,0.0009686874,0.05058581,0.01427851,0.013079,0.0009637796,0.00004603391,0.000004940281,7.622343e-7,0.000004754785,0.9053029,0.0009782205],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01242519,0.9833776,0.00009875074,0.00001858841,0.0005168648,0.003039586,0.00008454818,0.0002334329,0.0002054461],"genre_scores_gemma":[0.002009063,0.9954032,0.0001009475,0.000149518,0.001079743,0.00005880682,0.0002527433,0.0007068914,0.0002390758],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9138505,"threshold_uncertainty_score":0.9993899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07401050145086814,"score_gpt":0.3403840332688821,"score_spread":0.266373531818014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}